search
Back to results

JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer

Primary Purpose

Lower Urinary Tract Symptoms, Intravenous Drug Usage, Bladder Cancer

Status
Enrolling by invitation
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
JING SI HERBAL TEA
Placebo
Sponsored by
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Lower Urinary Tract Symptoms focused on measuring Intravesical installaion, Bladder cancer, Lower urinary tract symptoms, JING SI HERBAL TEA

Eligibility Criteria

20 Years - 100 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Clinical diagnosis bladder cancer Under intravesical installation therapy Exclusion Criteria: Patients under 20 years old or greater than 100 years old Women with pregnancy or breastfeeding plans Bladder cancer are being treated in another hospital Had admitted due to other disease in the past 3 months Unable to understand the questionnaire

Sites / Locations

  • Buddhist Tzu Chi General Hospital, Taipei branch

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Experimental (group 1)

Control (group 2)

Arm Description

This group will receive two sachets of JING SI HERBAL TEA a day (one in the morning and one in the evening).

This group will receive two sachets of placebo a day (same way as group 1).

Outcomes

Primary Outcome Measures

Urinary symptoms
Change from baseline score at the following time will be recorded. The American urological association symptom index is a 7-item self report measure to assess the urinary symptoms. The score range from 0 to 35, the higher the severity.

Secondary Outcome Measures

Life quality
Change from baseline score at the following time will be recorded. The 12-item shor form survey is a general health questionaire for life quality evaluation. The higher the value obtained, the more significant the impact on life.

Full Information

First Posted
January 13, 2023
Last Updated
February 20, 2023
Sponsor
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT05739071
Brief Title
JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer
Official Title
JING SI HERBAL TEA in the Treatment of Lower Urinary Tract Symptoms After Intravesical Therapy in Patients With Bladder Cancer
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Enrolling by invitation
Study Start Date
March 2023 (Anticipated)
Primary Completion Date
December 31, 2025 (Anticipated)
Study Completion Date
December 31, 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
To identify the effects of JING SI HERBAL TEA in the treatment of lower urinary tract symptoms after intravesical therapy in patients with bladder cancer.
Detailed Description
The patients with bladder cancer usually required trans urethral resection of bladder tumor (TUR-BT). Post-operative intravesical installation therapy is standard therapy. However, new onset lower urinary tract symptoms often occurred after these installation therapies. JING SI HERBAL TEA is a food contain of many herbal extracts with anti-inflammation effects. The current study is to find out the effects of JING SI HERBAL TEA in the treatment of this condition. The patients will be divided into two groups by randomly assigned (estimated case number=100, experimental: control = 1: 1). The first group will receive two sachets of JING SI HERBAL TEA a day (one in the morning and one in the evening). The second group will receive two sachets of placebo a day (same way as group 1). The therapy will be three days after each intravesical installation therapies. The outcome evaluations will use the American Urological Association Symptom Index and 12-Item Short Form Survey (SF-12). The baseline symptoms will be recorded before the first intravesical therapy. Patients will be asked to fill out the questionnaire every week (the same time for the next installation). Every other standard cancer therapies will not be will not be affected.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lower Urinary Tract Symptoms, Intravenous Drug Usage, Bladder Cancer, Herbal Interaction
Keywords
Intravesical installaion, Bladder cancer, Lower urinary tract symptoms, JING SI HERBAL TEA

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Double Blind (patients and attending physicians), parallel design Experimental group: JING SI HERBAL TEA, twice a day, every time 1 sachet for 3 days after each intravesical installation Control group: Placebo, twice a day, every time 1 sachet for 3 days after each intravesical installation
Masking
ParticipantCare Provider
Masking Description
Patients will be randomly assigned into the two groups with equal number. The JING SI HERBAL TEA and placebo have the same outer packaging. One dedicated researcher will be responsible for random allocation and administration, neither the patients nor the attending physicians (responsible for recording symptoms) knows the correct grouping.
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Experimental (group 1)
Arm Type
Experimental
Arm Description
This group will receive two sachets of JING SI HERBAL TEA a day (one in the morning and one in the evening).
Arm Title
Control (group 2)
Arm Type
Placebo Comparator
Arm Description
This group will receive two sachets of placebo a day (same way as group 1).
Intervention Type
Dietary Supplement
Intervention Name(s)
JING SI HERBAL TEA
Intervention Description
JING SI HERBAL TEA is a food, contain with herbal extracts
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
Placebo will have the same appearance as JING SI HERBAL TEA
Primary Outcome Measure Information:
Title
Urinary symptoms
Description
Change from baseline score at the following time will be recorded. The American urological association symptom index is a 7-item self report measure to assess the urinary symptoms. The score range from 0 to 35, the higher the severity.
Time Frame
The outcome evaluation will be at the following time points: 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks and 6 weeks
Secondary Outcome Measure Information:
Title
Life quality
Description
Change from baseline score at the following time will be recorded. The 12-item shor form survey is a general health questionaire for life quality evaluation. The higher the value obtained, the more significant the impact on life.
Time Frame
The outcome evaluation will be at the following time points: 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks and 6 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Clinical diagnosis bladder cancer Under intravesical installation therapy Exclusion Criteria: Patients under 20 years old or greater than 100 years old Women with pregnancy or breastfeeding plans Bladder cancer are being treated in another hospital Had admitted due to other disease in the past 3 months Unable to understand the questionnaire
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Shu-Yu Wu, bachelor
Organizational Affiliation
Taichung Tzu Chi Hospital
Official's Role
Study Director
Facility Information:
Facility Name
Buddhist Tzu Chi General Hospital, Taipei branch
City
Taipei
ZIP/Postal Code
231
Country
Taiwan

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
The JING SI HERBAL TEA and Placebo are provided by the Tzu Chi Medical Foundation. We can not determining whether there are sufficient materials to provide the other participants

Learn more about this trial

JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer

We'll reach out to this number within 24 hrs